KZR Kezar Life Sciences Inc

Price (delayed)

$5.49

Market cap

$264.01M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.92

Enterprise value

$246.32M

Highlights
The EPS is up by 47% year-on-year and by 3.2% since the previous quarter
The debt has contracted by 15% YoY and by 4.5% from the previous quarter
The quick ratio fell by 14% QoQ but it rose by 3.3% YoY
The net income has contracted by 19% YoY and by 7% from the previous quarter

Key stats

What are the main financial stats of KZR
Market
Shares outstanding
48.09M
Market cap
$264.01M
Enterprise value
$246.32M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.88
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$44.72M
EBITDA
-$43.17M
Free cash flow
-$37.11M
Per share
EPS
-$0.92
Free cash flow per share
-$0.73
Book value per share
$2.93
Revenue per share
$0
TBVPS
$2.98
Balance sheet
Total assets
$152.34M
Total liabilities
$11.7M
Debt
$5.22M
Equity
$140.64M
Working capital
$138.12M
Liquidity
Debt to equity
0.04
Current ratio
19.27
Quick ratio
18.82
Net debt/EBITDA
0.41
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-28.2%
Return on equity
-30.3%
Return on invested capital
-32.1%
Return on capital employed
-30.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KZR stock price

How has the Kezar Life Sciences stock price performed over time
Intraday
-2.83%
1 week
-2.66%
1 month
-2.31%
1 year
0.92%
YTD
5.17%
QTD
-7.89%

Financial performance

How have Kezar Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$45.52M
Net income
-$44.72M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 19% YoY and by 7% from the previous quarter
The company's operating income fell by 15% YoY and by 6% QoQ

Growth

What is Kezar Life Sciences's growth rate over time

Valuation

What is Kezar Life Sciences stock price valuation
P/E
N/A
P/B
1.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 47% year-on-year and by 3.2% since the previous quarter
The price to book (P/B) is 18% more than the last 4 quarters average of 1.6
KZR's equity is up by 15% year-on-year

Efficiency

How efficient is Kezar Life Sciences business performance
The company's return on invested capital rose by 23% YoY but it fell by 4.2% QoQ
KZR's ROE is up by 23% YoY but it is down by 3.8% QoQ
The return on assets is up by 20% year-on-year but it has declined by 4.1% since the previous quarter

Dividends

What is KZR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KZR.

Financial health

How did Kezar Life Sciences financials performed over time
The quick ratio fell by 14% QoQ but it rose by 3.3% YoY
KZR's current ratio is down by 14% since the previous quarter but it is up by 3.1% year-on-year
The debt is 96% less than the equity
KZR's debt to equity is down by 20% year-on-year
The debt has contracted by 15% YoY and by 4.5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.